Business

Novavax to Participate in BofA Securities 2025 Health Care Conference

GAITHERSBURG, Md., May 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care

Novavax, Inc.May 7, 20253
Novavax to Participate in BofA Securities 2025 Health Care Conference

About this update from Novavax, Inc.

GAITHERSBURG, Md. , May 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care Conference . Conference Details: Fireside Chat Date: Wednesday, May 14, 2025 Time: 3:00 – 3:30 p.m. Pacific Time (PT) Location: Las Vegas, NV Conference Event: Investor Meetings Date: Wednesday, May 14, 2025 A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days. About Novavax Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, which includes protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information. Contacts: Investors Luis Sanay , CFA 240-268-2022 [email protected] Media Giovanna Chandler 202-709-5563 [email protected] View original content to download multimedia: https://www.prnewswire.com/news-releases/novavax-to-participate-in-bofa-securities-2025-health-care-conference-302447909.html SOURCE Novavax, Inc.

View stock analysis, news, and events for Novavax, Inc.

More from Novavax, Inc.

All Novavax, Inc. news →